Astonea Labs Limited shareholders unanimously approved all agenda items at its ninth annual general meeting held on August 21, 2026. The key resolution included the re-appointment of Ms. Pooja Singh as a director.

Ms. Singh, who holds a Bachelor of Pharmacy degree and possesses over eight years of experience in the pharmaceutical industry, was liable to retire by rotation. She currently heads the Drug Regulatory Affairs Department and serves on the CSR Committee. She has no shareholding in the company and is not related to any other director or key managerial personnel.

The meeting took place at the Mercure Hotel in Chandigarh, marking the first such gathering since the company’s securities were listed. Six members attended the physical session, satisfying quorum requirements under Section 103 of the Companies Act, 2013.

Financial Results Adopted

Shareholders adopted the audited standalone and consolidated financial statements for FY26. The company reported revenue of approximately ₹148 crore and a profit after tax (PAT) of approximately ₹4.51 crore for the financial year ended March 31, 2026.

Voting Participation Breakdown

The total outstanding shares stood at 10,511,000. Of these, 7,839,000 votes were polled through the National Securities Depository Limited (NSDL) e-voting facility. No votes were cast via ballot paper during the physical meeting.

Promoters held 7,599,970 shares and voted nearly all their holdings (99.93%). Public non-institutional investors participated at a lower rate of 9.91%, while institutional public shareholders did not vote.

Other Resolutions Approved

All resolutions passed with unanimous support from the voting members. Additional approvals included:

• Ratification of remuneration for M/s. Balwinder & Associates as Cost Auditor for FY27.
• Alteration in the Object Clause of the Memorandum of Association.
• Approval for incorporation and investment in subsidiary companies in India.

Governance and Compliance

Mr. Sahil Malhotra of SV & Associates served as the scrutinizer for the voting process. He confirmed that the e-voting facility was open from August 18 to August 20, 2026. The consolidated voting results were submitted to the BSE within two working days as per SEBI Listing Regulations.

Ashish Gulati, Chairman, presided over the session. He highlighted the company’s focus on strengthening pharmaceutical and allied operations while maintaining regulatory compliance and corporate governance standards.

Astonea Labs Limited has scheduled its 9th Annual General Meeting (AGM) for August 21, 2026, to seek shareholder approval for significant strategic expansions, including alterations to its Memorandum of Association and the incorporation of new subsidiary companies. The meeting will be held in physical mode at Mercure Hotel in Chandigarh, where members will also vote on the re-appointment of Director Ms. Pooja Singh and the ratification of cost auditor remuneration.

The Board of Directors approved the notice for the AGM on July 24, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 102 of the Companies Act, 2013. The company is providing remote e-voting facilities through National Securities Depository Limited (NSDL), with the voting window open from August 18 to August 20, 2026. The cut-off date for determining eligibility for voting is August 14, 2026.

Key Resolutions

The AGM agenda comprises three ordinary businesses and three special resolutions. The most material items involve structural changes to facilitate future growth:

Strategic Expansion via MOA Amendment

The proposed alteration to the Object Clause of the Memorandum of Association aims to align the company’s legal framework with its growth strategy. The amendment will explicitly permit Astonea Labs to manufacture, formulate, process, and trade a wider range of products, including antibiotics, biologicals, vaccines, ayurvedic products, and dietary supplements. Furthermore, it enables the company to utilize diverse commercial channels such as e-commerce platforms, digital marketplaces, and franchise arrangements for distribution. This flexibility is intended to support long-term business objectives without adversely affecting member or creditor rights.

Subsidiary Investments

Shareholders are also being asked to approve the incorporation and investment in subsidiary companies in India. This resolution provides the Board with the authority to promote and subscribe to share capital in new entities to create focused business verticals and achieve operational efficiencies. The company noted that an aggregate investment limit of ₹100 crore was previously approved by members at an Extra-Ordinary General Meeting held on March 27, 2026, under Section 186 of the Companies Act, 2013.

Meeting Logistics

The register of members and share transfer books will remain closed from August 15 to August 21, 2026, for the purpose of the AGM. Members holding shares in physical form are advised to ensure their KYC details are updated with the Registrar and Transfer Agent, KFin Technologies Ltd. The scrutinizer for the e-voting process is Mr. Sahil Malhotra (Membership No. A38204).